Higher tech: Pittsburgh's Cognistx using AI to identify psychedelic drugs to treat depression, anxiety and PTSD
Higher tech: Pittsburgh’s Cognistx using AI to identify psychedelic drugs to treat depression, anxiety and PTSD It could be a trip worth taking — the final frontier for psychiatry may actually be psychedelics. Maligned for decades as dangerous, illegal substances, psychedelic drugs such as psilocybin (“magic mushrooms”) LSD and mescaline are being studied as potential game-changers for alleviating treatment-resistant psychiatric problems, ranging from anxiety and depression to post-traumatic stress disorder. Cognistx, a Carnegie Mellon University spinoff based in Downtown Pittsburgh, ...
Source: nextpittsburgh.com